Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease.

Abás S, Rodríguez-Arévalo S, Bagán A, Griñán-Ferré C, Vasilopoulou F, Brocos-Mosquera I, Muguruza C, Pérez B, Molins E, Luque FJ, Pérez-Lozano P, de Jonghe S, Daelemans D, Naesens L, Brea J, Loza MI, Hernández-Hernández E, García-Sevilla JA, García-Fuster MJ, Radan M, Djikic T, Nikolic K, Pallàs M, Callado LF, Escolano C.

J Med Chem. 2020 Mar 19. doi: 10.1021/acs.jmedchem.9b02080. [Epub ahead of print]

PMID:
32150414
2.

In silico identification of novel 5-HT2A antagonists supported with ligand- and target-based drug design methodologies.

Radan M, Ruzic D, Antonijevic M, Djikic T, Nikolic K.

J Biomol Struct Dyn. 2020 Mar 17:1-19. doi: 10.1080/07391102.2020.1738961. [Epub ahead of print]

PMID:
32141385
3.

Deciphering Imidazoline Off-Targets by Fishing in the Class A of GPCR field.

Djikic T, Vucicevic J, Laurila J, Radi M, Veljkovic N, Xhaard H, Nikolic K.

Mol Inform. 2020 Feb 20. doi: 10.1002/minf.201900165. [Epub ahead of print]

PMID:
32078760
4.

In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs.

Gagic Z, Ruzic D, Djokovic N, Djikic T, Nikolic K.

Front Chem. 2020 Jan 8;7:873. doi: 10.3389/fchem.2019.00873. eCollection 2019. Review.

5.

Severe hepatotoxicity induced by efavirenz in a treatment-naïve, low body mass index HIV-infected, female patient with no hepatitis and other virus co-infections.

Dragovic G, Nikolic K, Dimitrijevic B, Jevtovic D, Salemovic D, Tomanovic N, Boricic I.

Ultrastruct Pathol. 2019;43(4-5):220-223. doi: 10.1080/01913123.2019.1673862. Epub 2019 Oct 2.

PMID:
31578116
6.

Structure-based design of selective histone deacetylase 6 zinc binding groups.

Alves Avelar LA, Ruzic D, Djokovic N, Kurz T, Nikolic K.

J Biomol Struct Dyn. 2019 Aug 14:1-12. doi: 10.1080/07391102.2019.1652687. [Epub ahead of print]

PMID:
31382868
7.

Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling.

Bouchet S, Linot C, Ruzic D, Agbaba D, Fouchaq B, Roche J, Nikolic K, Blanquart C, Bertrand P.

ACS Med Chem Lett. 2019 May 9;10(6):863-868. doi: 10.1021/acsmedchemlett.8b00440. eCollection 2019 Jun 13.

PMID:
31223439
8.

Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-Targets.

Stevanovic S, Sencanski M, Danel M, Menendez C, Belguedj R, Bouraiou A, Nikolic K, Cojean S, Loiseau PM, Glisic S, Baltas M, García-Sosa AT.

Molecules. 2019 Apr 2;24(7). pii: E1282. doi: 10.3390/molecules24071282.

9.

Modulating Protein-Protein Interactions with Visible-Light-Responsive Peptide Backbone Photoswitches.

Albert L, Peñalver A, Djokovic N, Werel L, Hoffarth M, Ruzic D, Xu J, Essen LO, Nikolic K, Dou Y, Vázquez O.

Chembiochem. 2019 Jun 3;20(11):1417-1429. doi: 10.1002/cbic.201800737. Epub 2019 Apr 25.

PMID:
30675988
10.

Combined Ligand and Fragment-based Drug Design of Selective Histone Deacetylase - 6 Inhibitors.

Ruzic D, Petkovic M, Agbaba D, Ganesan A, Nikolic K.

Mol Inform. 2019 May;38(5):e1800083. doi: 10.1002/minf.201800083. Epub 2019 Jan 11.

PMID:
30632697
11.

Investigation and prediction of retention characteristics of imidazoline and serotonin receptor ligands and their related compounds on mixed-mode stationary phase.

Obradović D, Oljačić S, Nikolić K, Agbaba D.

J Chromatogr A. 2019 Jan 25;1585:92-104. doi: 10.1016/j.chroma.2018.11.051. Epub 2018 Nov 23.

PMID:
30553503
12.

Ultra-performance liquid chromatography tandem mass spectrometry for the rapid, simultaneous analysis of ziprasidone and its impurities.

Čarapić M, Nikolic K, Marković B, Petković M, Pavlovic M, Agbaba D.

Biomed Chromatogr. 2019 Feb;33(2):e4384. doi: 10.1002/bmc.4384. Epub 2018 Oct 17.

PMID:
30215855
13.

А theoretical study on ionization of sartans in aqueous media and on interactions with surfactant micelles.

Popović-Nikolić MR, Popović GV, Grujić M, Nikolić KM, Agbaba DD.

J Mol Graph Model. 2018 Jun;82:67-73. doi: 10.1016/j.jmgm.2018.04.008. Epub 2018 Apr 20.

PMID:
29704812
14.

A perspective on multi-target drug discovery and design for complex diseases.

Ramsay RR, Popovic-Nikolic MR, Nikolic K, Uliassi E, Bolognesi ML.

Clin Transl Med. 2018 Jan 17;7(1):3. doi: 10.1186/s40169-017-0181-2.

15.

The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot .

Mucaji P, Atanasov AG, Bak A, Kozik V, Sieron K, Olsen M, Pan W, Liu Y, Hu S, Lan J, Haider N, Musiol R, Vanco J, Diederich M, Ji S, Zitko J, Wang D, Agbaba D, Nikolic K, Oljacic S, Vucicevic J, Jezova D, Tsantili-Kakoulidou A, Tsopelas F, Giaginis C, Kowalska T, Sajewicz M, Silberring J, Mielczarek P, Smoluch M, Jendrzejewska I, Polanski J, Jampilek J.

Molecules. 2017 Oct 28;22(11). pii: E1848. doi: 10.3390/molecules22111848.

16.

Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta-analysis.

Villablanca PA, Mohananey D, Nikolic K, Bangalore S, Slovut DP, Mathew V, Thourani VH, Rode's-Cabau J, Núñez-Gil IJ, Shah T, Gupta T, Briceno DF, Garcia MJ, Gutsche JT, Augoustides JG, Ramakrishna H.

Catheter Cardiovasc Interv. 2018 Feb 1;91(2):330-342. doi: 10.1002/ccd.27207. Epub 2017 Jul 24.

PMID:
28738447
17.

Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches.

Vucicevic J, Nikolic K, Mitchell JBO.

Curr Med Chem. 2019;26(21):3874-3889. doi: 10.2174/0929867324666170712115411. Review.

PMID:
28707592
18.

3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity.

Oluić J, Nikolic K, Vucicevic J, Gagic Z, Filipic S, Agbaba D.

Comb Chem High Throughput Screen. 2017 Aug 10;20(4):292-303. doi: 10.2174/1386207320666170427143858.

PMID:
28460621
19.

Evaluation of Biological Activity and Computer-Aided Design of New Soft Glucocorticoids.

Dobričić V, Jaćević V, Vučićević J, Nikolic K, Vladimirov S, Čudina O.

Arch Pharm (Weinheim). 2017 May;350(5). doi: 10.1002/ardp.201600383. Epub 2017 Apr 18.

PMID:
28418199
20.

Peroral endoscopic myotomy: procedural complications and pain management for the perioperative clinician.

Misra L, Fukami N, Nikolic K, Trentman TL.

Med Devices (Auckl). 2017 Feb 23;10:53-59. doi: 10.2147/MDER.S115632. eCollection 2017.

Supplemental Content

Loading ...
Support Center